Cost Minimization Analysis of Onsite Cytopathologist (CyP) Evaluation During EUS FNA of Solid Pancreatic Lesions (SPL)

Availability of onsite CyP evaluation during EUS FNA of SPL can increase diagnostic yield of malignancy with a significantly lower number of EUS-FNA passes. However, studies on clinical impact of onsite CyP have reported conflicting results and considerable additional resources are required to have...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Azar, Riad R. (author)
مؤلفون آخرون:	Wani, Sachin (author), Rastogi, Amit (author), Early, Dayna S. (author), Mullady, Daniel (author), Collins, Brian T. (author), Wang, Jeff F. (author), Yen, Roy D. (author), Sams, Sharon B. (author), Marshall, Carrie (author)
التنسيق:	article
منشور في:	2013
الوصول للمادة أونلاين:	http://hdl.handle.net/10725/4448 http://dx.doi.org/10.1016/j.gie.2013.03.591 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php http://www.giejournal.org/article/S0016-5107(13)00806-7/abstract
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

الوصف
الملخص:	Availability of onsite CyP evaluation during EUS FNA of SPL can increase diagnostic yield of malignancy with a significantly lower number of EUS-FNA passes. However, studies on clinical impact of onsite CyP have reported conflicting results and considerable additional resources are required to have onsite CyP available at a facility.

Cost Minimization Analysis of Onsite Cytopathologist (CyP) Evaluation During EUS FNA of Solid Pancreatic Lesions (SPL)

مواد مشابهة